NEUROCRINE BIOSCIENCES INC (NBIX) Net margin 2016–2025
NEUROCRINE BIOSCIENCES INC (NBIX) net profit margin by fiscal year — reported net income divided by reported revenue.
16.7%FY2025 · since FY2016: -940.6% → 16.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 16.7% | +2.2 pp |
| FY2024 | 14.5% | +1.3 pp |
| FY2023 | 13.2% | +2.9 pp |
| FY2022 | 10.4% | +2.5 pp |
| FY2021 | 7.9% | -31.0 pp |
| FY2020 | 38.9% | +34.2 pp |
| FY2019 | 4.7% | +0.0 pp |
| FY2018 | 4.7% | +92.9 pp |
| FY2017 | -88.2% | +852.4 pp |
| FY2016 | -940.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NBIX financial trends
NBIX RevenueNBIX Net incomeNBIX Gross profitNBIX Gross marginNBIX Operating incomeNBIX Operating marginNBIX Operating cash flowNBIX Free cash flowNBIX Capital expendituresNBIX Return on equityNBIX Stock buybacksNBIX Dividends paidNBIX Total assetsNBIX Total liabilitiesNBIX Shareholders’ equityNBIX overview →